Bausch Health Companies (TSE:BHC) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Bausch Health Companies (TSE:BHC) announced its quarterly earnings results on Wednesday. The company reported C$1.53 earnings per share for the quarter, beating the consensus estimate of C$1.43 by C$0.10, reports. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. The business had revenue of C$3.42 billion during the quarter, compared to analysts’ expectations of C$3.36 billion.

Bausch Health Companies Trading Up 6.6 %

TSE:BHC opened at C$13.65 on Friday. The company has a 50-day moving average price of C$10.04 and a 200-day moving average price of C$9.86. The stock has a market cap of C$5.01 billion, a price-to-earnings ratio of -7.80, a P/E/G ratio of 0.21 and a beta of 0.77. The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of 7,583.76. Bausch Health Companies has a 12 month low of C$5.45 and a 12 month high of C$15.43.

Insider Activity at Bausch Health Companies

In other news, Senior Officer Seana Lynne Carson sold 13,370 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of C$8.38, for a total value of C$112,087.40. 11.28% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on BHC shares. Raymond James upgraded shares of Bausch Health Companies to a “hold” rating in a report on Wednesday, July 10th. Evercore ISI upgraded Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.